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ABSTRACT
The relative efficacy of secondary packaging on the prevention of microbial ingress into sterile medical 
device trays was examined.
Sterile device trays were aseptically filled with growth medium, exposed to microbial challenge, incubated, 
and inspected for growth.  During microbial challenge, all package systems were subjected to a pressure 
differential that simulated those experienced during distribution.  
Penetration rates were significantly decreased (P = 0.01) when unlidded trays were packaged in pouches 
(0/39), compared to those in cartons (37/39).  Similarly, the number of colony forming units (CFU) present 
was greater for unlidded trays packaged in cartons, compared to those in pouches (P = 0.03).  To further 
explore the efficacy of cartons as a barrier to microbial ingress, lidded trays with a single 100 μm breach 
were packaged in cartons and subjected to the same methodologies; approximately 15% exhibited growth. 
When compared to unlidded trays, penetration rates (P<0.0001) and number of CFU decreased (P=0.0048).
Microbial penetration was more prevalent for sterile trays packaged within cartons than in pouches.  While 
folding cartons are not intended to perform as sterile barriers, this suggests that microbial penetration is 
more likely to occur for trays packaged within cartons than those in pouches.  
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INTRODUCTION
 The US healthcare industry continues to be one 
of the largest, most diverse, and fastest growing 
industries in the country, and healthcare spending 
continues to escalate.  Total spending was $2.2 
trillion in 2007, or $7,900 per person, representing 
17% of the gross domestic product (GDP). 
Similar rates of increase are expected over the next 
decade and it is estimated that by 2017, healthcare 
spending will reach $4.3 trillion, or approximately 
20% of the GDP.1, 2
 Although many factors contribute to the rising 
cost of healthcare, one issue of significant concern 
has been the prevalence of hospital/healthcare-
associated infections (HAIs).3,4  HAIs are defined as 
an infection that is “acquired while an individual is 
a patient at a hospital that was neither present nor 
incubating in the patient prior to receiving services 
in the hospital (Food and Drug Administration 
Amendments Act, 2007). It has been indicated 
that there are nearly 1.7 million HAIs annually in 
the US3 which result in costs of $5-6 billion and 
nearly 100,000 deaths.6  This has led to aggressive 
strategies to diagnose and treat infections, as well 
as prevent infection and transmission.7  Prevention 
strategies have primarily focused on the intelligent 
use of antimicrobials, changes in institutional 
policy, and improved hygiene techniques.8,9
 Although not frequently investigated or 
implicated, medical devices are also a potential 
source of microbes and an important risk factor for 
HAIs10,11 that should be considered in prevention 
strategies.  The use of invasive devices has been 
linked with the most prevalent types of HAIs.12 
Hence, medical devices could serve as infection 
catalysts if not properly packaged to survive the 
rigors of distribution and handling or designed in a 
way that facilitates sterile technique.
 Package integrity, or the ability of a package 
to maintain its sterile barrier throughout the 
distribution process, is of paramount importance 
in the medical device industry.13  More specifically, 
the question of “penetration threshold”, the 
smallest size defect that allows microbial 
penetration, is of critical, practical relevance.14 
An integrity test that fails packages that do not 
present health risks may needlessly increase costs 
when the package and product are destroyed 
unnecessarily.  Conversely, integrity tests that pass 
packages containing breaches that allow microbial 
penetration constitute important health risks to 
patient safety.  This tension of opposites is further 
compounded by the fact that new integrity testers 
are increasingly sensitive, finding smaller and 
smaller breaches.15  In the absence of consistent, 
scientifically obtained information regarding the 
penetration threshold, diligent companies throw 
out any package in which they find a breach. 
Recalls are made based on the potential for a 
breach in integrity, as opposed to a known breach 
of integrity.  This is a conservative, but costly, 
approach.
 Of additional interest is the fact that the primary 
package, the package in contact with the product 
(also called the sterile barrier system (SBS), is 
frequently packaged inside another “secondary” 
package (also called the protective package).  The 
secondary packaging of medical devices is varied 
and commonly includes folding cartons, pouches, 
and wraps.  In general, the purpose of secondary 
packaging is to provide physical protection for the 
SBS; however, the potential role of the secondary 
package as an additional barrier for microbes is 
unclear.
 With the ultimate goal of effectively protecting 
patient safety, investigation of the relative efficacy 
of secondary packages to prevent microbial ingress 
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into SBSs is warranted.  Surprisingly, limited 
work has been done on the broad area of microbial 
ingress and medical device packages,14, 16-18 and 
our search of the literature exposed a broad gap 
in knowledge regarding the effect of secondary 
packaging on microbial penetration.
OBJECTIVE
The objective was to conduct a comparative study 
examining the relative efficacy of secondary 
packaging (folding cartons vs. pouches) to prevent 
microbial ingress into sterile medical device trays. 
METHODS
The study consisted of two specific questions:
 Question 1:  What is the relative effect of 
secondary package type on microbial penetration 
of sterile medical device trays?  Tested secondary 
packages were:
• a solid bleached sulfate folding carton 0.015” 
manufactured on an Artios Kongsberg 
Premium Line 1930 (Figure 1a),
• and a 7.25” x 9.50” plastic pouch (100GA 
biaxially oriented Nylon 0.001, 0.0007 LDPE, 
0.002 HDPE coex Lot # H150978/1/A) 
(Mangar Industries, Inc., New Britain, PA), 
sealed on a SenCorp (Hyannis, MA) CeraTek 
Model No. 24AS/1 Serial No. 06-04236 at 
the following conditions: 275°F, 60 psi, 1 s 
(Figure 1b).
In order to robustly test the efficacy of secondary 
packaging as a microbial barrier, all medical device 
trays used for Question 1 were left unlidded inside 
the secondary packages.  Although unrealistic, this 
created an extreme condition where sterility was 
dependent on the secondary packaging only. Trays 
were randomly assigned to pouches and cartons as 
secondary packages (Figure 1).
 Question 2:  Given a carton as the secondary 
package, does the presence of a lid affect the 
microbial penetration of trays?   
 For this purpose, unlidded trays were compared 
with lidded trays with 100 μm breaches, after both 
treatments had been packaged in cartons.  Trays 
packaged individually within cartons were assigned 
to the absence/presence of a lid and orientation, as 
follows:  a) unlidded trays sitting on their bottoms, 
and b) lidded trays sitting on their lids with bottoms 
facing up; tray bottoms contained a single 100 μm 
breach.  Treatment b was intended to represent a 
more realistic context for the primary packaging 
and, therefore, was the only treatment to contain 
the 100 μm breach.  Combinations of primary and 
secondary packaging (the test configurations) are 
henceforth referred to as “samples”.
 A total of 120 samples were used to investigate 
the specific Questions 1 and 2 of the study 
objective.  All trays were unlidded glycol modified 
polyethylene terephthalate (PETG) (Perfecseal, 
Mankato, MN)).  Forty of the samples were 
unlidded trays sealed in individual pouches, 40 
were unlidded trays packaged individually in 
cartons, and the remaining 40 were lidded trays 
packaged individually in cartons.  The latter, 
Figure 1 - Unlidded trays contained in secondary 
packaging, with septa:  (a) carton, (b) pouch
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lidded trays in cartons, each contained a 100 µm 
(+/- 10%) thermal laser drilled pinhole (Lenox 
Laser, Glen Arm, MD) and were sealed with a 
nonporous lid.  An MD2420 dual-shuttle heat 
sealer (Sencorp, Hyannis, MA) was used to seal 
the lids, LKF-002 Paper/PE/Foil/PE/HSC die 
cut lids (Amcor Flexibles, Madison, WI), to the 
trays.  Batch and die positions for were recorded 
and sealing conditions were 300°F, 70 psi, 2.5 s. 
A Teflon® impregnated fiber glass cloth (Green 
Belting Industries, Ltd., Buffalo, NY) was used to 
prevent scorching and burning.  All pinholes were 
size certified by the laser company using flow. 
Holes were also confirmed and characterized 
(post sealing) by the MSU team using a microflow 
detection technique manufactured by ATC, Inc. 
(Indianapolis, IN).
 Self-sealing septa (Illinois Instruments, 
Johnsburg, IL) were applied to the primary 
packages (trays) and their secondary packages 
(cartons or pouches) at two locations which served 
as the sites for sterile growth medium injection 
(septum location 1) and pressure differential 
inducement (septum location 2) (Figure 1).  For 
the samples with lidded trays, a septum was placed 
on the center of each tray lid; this eventually 
aligned with a septum on the carton so that, 
together, they served as the injection site for sterile 
agar (hereafter referred to as septum 1).  Unlidded 
trays did not receive septa at this location as there 
was no lidstock to hold it.  Additionally, a septum 
(hereafter referred to as septum 2) was placed 
in a standardized location at the end of all trays; 
this site served as the location for the insertion of 
a needle used to remove a known volume of air, 
inducing a pressure differential across the package 
(Figures 1a and 1b).  After application of all septa, 
trays were inserted into the appropriate secondary 
package (pouch or carton).
Septa were also added to all secondary packages 
(i.e. carton or pouch) at the top center (directly 
above septum 1 in the case of the lidded trays), 
and at the end so that they aligned with septum 2 
(Figures 1 and 2).  Packaged trays were shipped 
to Smith & Nephew, Inc. (Memphis, TN) and 
gamma sterilized by Sterigenics (West Memphis, 
AR).  Packages were returned to MSU after being 
sterilized.
 All samples were uniquely identified and 
aseptically injected with sterile growth medium. 
Just prior to filling each tray, septum 1 on the 
secondary package was swabbed with 70% 
isopropyl alcohol to prevent contamination.  Trays 
were injected through septum 1 with molten sterile 
nutrient growth agar that was prepared by the 
Media Prep Lab at Michigan State University (East 
Lansing, MI).  Each aliquot of agar was contained 
in its own stoppered bottle; this prevented the need 
to draw from the same growth medium multiple 
times, minimizing the chance for unintentional 
contamination.  The foam bottle stoppers were 
swabbed with 70% isopropyl alcohol and a 60 
mL syringe outfitted with an 18 gauge needle 
was pierced through each stopper to draw up 30 
mL of agar.  Then, the needle was changed to a 
16 gauge vented needle, which was used to inject 
the agar into the packaged trays through septum 
1 (Figure 1).  For detailed procedures regarding 
microbiological techniques please reference 
Severin.14
 Both lidded and unlidded trays were filled from 
the lid side; however, the orientation during filling 
was different.  Lidded trays were oriented with their 
lidstock down, so that the growth medium rested 
on the lid and did not contact the 100 μm hole that 
had been drilled in the bottom of the tray.  Unlidded 
trays were filled in the opposite orientation, so that 
the agar rested inside the bottom of the tray.   
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 After the trays were filled with agar, they were 
loaded into an aerosolizing microbial challenge 
chamber built by the research team14 (Figures 2 and 
3) in batches of four.  Their orientations remained 
the same as when filled with agar; lidded trays 
sat on their lids inside the cartons so that the 100 
μm holes drilled in the centers of the tray bottoms 
faced up and unlidded trays were positioned with 
the open portions of the trays facing up inside 
the secondary packages.  Since the aerosolized 
spray came from the top of the chamber, these 
orientations were intended to induce worst-case 
conditions for microbial penetration in an effort to 
conservatively evaluate the relative performance 
of the treatments of interest.
 Syringes used to induce pressure differential 
were then positioned in a racking system within 
the chamber.  Septum 2 on the exterior of the 
secondary packages was swabbed with 70% 
isopropyl alcohol and then a syringe outfitted with 
an 18 gauge needles was pierced through it.  This 
completed setup within the chamber, which was 
then closed.
 Escherichia coli K-12 (ATCC Number 29181), 
a gram-negative, motile, straight-rod bacterium 
ranging in size from 1.1-1.5 x 2.0-6.0 μm was 
aerosolized using a starting concentration of 
10^6 based on work conducted by Keller.19  E. 
coli K-12 was chosen for several reasons.  It is 
a non-pathogenic, ubiquitous microorganism 
routinely used in laboratories at MSU.  It is also 
smaller than Bacillus subtilis, the spores of which 
are commonly used in medical device microbial 
challenge studies15, 20-23 and, as a result, a more 
severe challenge of the sterile barrier. 
 For each batch of samples, the E. coli solution 
was aerosolized for 15 seconds and total exposure 
time in the chamber was 30 minutes.  Pressure 
differential was induced simultaneously for all 
four trays per batch by slowly retracting the syringe 
racking system built into the chamber (Figures 
2 and 3).  The rate of air withdrawal was held 
constant by retracting the system over a one minute 
period.  Pressure differential has been shown to 
have a significant effect on microbial penetration 
of these14,18 and other similar systems.24,25  This 
Figure 2 - Top view of aerosolization chamber when loaded with trays con-
tained in cartons:  (a) before inducement of pressure, (b) after inducement 
of pressure by pulling the syringe racking system utilizing built-in gloves
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is of practical relevance, as pressure differentials 
may be generated during the course of product 
distribution, such as during the descent of an 
aircraft or descent of a vehicle down a mountain 
pass.  The removal of 62 mL of air from the 
package was intended to simulate a descent from 
an altitude of approximately 8,000ft.14  
 
 After exposure in the aerosol chamber, 
trays were incubated at 37°C and 50% RH for 
approximately 24 hours.  Following the incubation 
period, trays were visually examined for microbial 
growth and colony counts were conducted (Figure 
4).  A single colony from each tray that exhibited 
growth was verified as the test organism (E. coli 
K-12) using an Enterotube II Identification System 
for Enterobacteriaceae (Becton Dickinson, San 
Jose, CA).
 Of the 120 samples, usable data was obtained 
from 118.  Two unlidded trays, one in a pouch 
and the other in a carton, were removed from the 
study due to technical problems associated with 
inadvertent puncture with the syringes.
  
STATISTICAL METHODS
 Microbial penetration in each tray was recorded 
as binary (penetration: yes/no) and count response 
variables (number of CFU).  Each response 
variable was modeled using a separate generalized 
linear mixed model assuming a binomial and an 
overdispersed Poisson distribution, respectively. 
The linear predictor in each model included the 
fixed effect of treatment (secondary package 
type or level of exposure for Questions 1 and 2, 
respectively), and the random effect of challenge 
batch nested within treatment, in order to account 
for technical replication present in the design. 
Models were fitted with the GLIMMIX procedure 
of SAS (SAS version 9.2, SAS Institute Inc., 
Cary, NC).  The marginal log likelihood was 
approximated using an adaptive Gauss-Hermite 
quadrature method in order to facilitate model 
convergence.  Due to an extreme category problem 
(quasi-complete separation of data points given by 
no penetration in any of the trays assigned to the 
pouch), the effect of treatment in Question 1 was 
modeled as a random effect in a Bayesian-type 
approach.  Sensitivity analyses were performed 
using starting values for the random treatment 
Figure 4 - Unlidded tray exhibiting growth
Figure 3 - Aerosolization chamber:  (a) during 
aerosolization, (b) loaded with trays in pouches, 
(c) loaded with trays in cartons
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variance of 1, 10, 100, 1000 and 10000.  Variance 
estimates and treatment differences were not 
affected by the starting values considered, thus the 
proposed Bayesian analysis was considered robust 
and used for inference.  Contrasts were used 
to compare treatments.  Estimated least square 
means and standard errors of the probability of 
penetration, as well as CFU, were reported.
RESULTS
 Question 1:  What is the relative effect of 
secondary package type on microbial penetration 
of sterile medical device trays? 
  None of the unlidded trays in pouches exhibited 
microbial growth.  In contrast, most of the unlidded 
trays in cartons did (n=39).
 Secondary packaging was identified to 
have a significant effect on the probability of 
microbial penetration when the contained medical 
device trays were unlidded (P=0.01); microbial 
penetration was more likely for trays packaged 
within cartons than for those within pouches 
(Figure 5a).  The number of CFU per unlidded tray 
was also significantly greater when packed within 
cartons than within pouches (P = 0.03) (Figure 
5b).
 Question 2:  Given a carton as the secondary 
package, does the presence of a lid affect the 
microbial penetration of trays?   
 
 Level of exposure (lidded or unlidded) affected 
the probability of microbial penetration into 
the trays packaged within cartons (P<0.0001). 
Microbial penetration of medical device trays 
inside cartons was more likely to occur with 
unlidded trays compared to lidded (Figure 6a). 
In addition, the presence or absence of a lid 
had a significant effect on the number of CFU 
(P=0.0048), such that the number of CFU that 
entered trays within cartons was greater when they 
were unlidded compared to lidded (Figure 6b).
DISCUSSION
 This study suggests differences in both the 
rates of contamination and number of CFU that 
penetrated trays when pouches were compared 
with cartons as secondary packages.  The pouches 
outperformed the cartons as effective secondary 
packaging barriers to microbial ingress, as shown 
with the rates of penetration and number of CFU. 
Figure 5 - Estimated least square means and standard errors for: (a) probability of microbial 
penetration, and (b) number of CFU for unlidded trays in pouches and cartons
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These results are not surprising given the sealed 
structure of the pouch, which contrasts with 
the presence of unsealed crevices of the carton. 
It is also notable that the microbial challenge 
conditions used were intended to be substantially 
more extreme than normal expected conditions of 
shipment.  
 
 We acknowledge that unlidded trays are not 
realistic in a medical setting; however, they were 
used in this study as a control to assess microbial 
ingress through secondary packages into device 
trays presented under commercial conditions, as 
represented by the lidded treatment for Question 2. 
The lidded trays with pinhole defects experienced 
microbial penetration in 15% (6/40) of the tested 
trays despite the presence of the carton.
 Packaged medical devices have to survive 
sterilization, shipping, and handling with their 
sterile barrier systems (SBSs) intact.  Packaging 
manufacturers and the device companies that 
employ them do not consider secondary packaging 
as part of the SBS or purport that they provide 
microbial barrier.13  Other benefits and determents 
of secondary packaging systems also come into 
consideration when making a packaging decision, 
such as stacking capabilities, billboard, barrier, 
and cost, among others.  
 Results presented in this study have direct 
implications for patient safety.  Due to high rates of 
nosocomial infections,5,9,26 package integrity (the 
ability of a package to maintain its sterile barrier) 
is imperative.  At the same time, a reduction in the 
cost of healthcare is viewed as a national, if not 
international, need.1,2  Understanding the precise 
conditions in which microbial penetration occurs 
and the level of benefit (protection, identification, 
convenience, etc.) packaging systems afford is of 
paramount importance.  The rates and treatment 
challenges of healthcare-associated infections, and 
the potential for devices to serve as reservoirs for 
microorganisms, make further study of this issue 
imperative.
LIMITATIONS
 The self-built tailored-approach used to address 
the research questions had logistical limitations 
Figure 6 - Estimated least square means and standard errors of (a) probability of microbial 
penetration, and (b) number of CFU for unlidded and lidded trays in cartons
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that caused concerns over the experimental 
design.  Specifically, packaged trays grouped in 
batches of four were tested in a sequential manner: 
first unlidded trays within pouches, then unlidded 
trays within cartons, and finally, lidded trays 
within cartons.  This sequential order of treatment 
evaluation was due to a logistical limitation of 
physical adjustments that had to be made to the 
racking system of the aerosolizing chamber at each 
treatment switch.  We acknowledge the potential 
for an ordering effect to be partially confounded 
with the reported treatment effects.
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